Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Emilie Lalonde
Affiliation
University of Pennsylvania
ORCID
Career Start Year
2010
Papers
34
H Index
23
Expertise
CM4AI Collaborator
Timothy Clark (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36249692
Improved Uveal Melanoma Copy Number Subtypes Including an Ultra-High-Risk Group.
Ophthalmol Sci
2022
33832921
Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
Cold Spring Harb Mol Case Stud
2021
32733828
Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution.
Front Pediatr
2020
30643250
Molecular landmarks of tumor hypoxia across cancer types.
Nat Genet
2019
30761771
Molecular diagnosis of somatic overgrowth conditions: A single-center experience.
Mol Genet Genomic Med
2019
30665349
BPG: Seamless, automated and interactive visualization of scientific data.
BMC Bioinformatics
2019
29112706
NanoStringNormCNV: pre-processing of NanoString CNV data.
Bioinformatics
2018
30477459
Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
BMC Cancer
2018
29681457
The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.
Cell
2018
29295717
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
BMC Cancer
2018
28068672
Genomic hallmarks of localized, non-indolent prostate cancer.
Nature
2017
28077964
Erratum to: A bedr way of genomic interval processing.
Source Code Biol Med
2017
28376164
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
J Natl Cancer Inst
2017
28286059
Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.
EBioMedicine
2017
29312903
Clinical Impact of Genomic Information in Pediatric Leukemia.
Front Pediatr
2017
28511883
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
Eur Urol
2017
28828481
PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma.
Invest Ophthalmol Vis Sci
2017
27815082
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Eur Urol
2017
27079753
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.
Alzheimers Dement
2016
27999613
A bedr way of genomic interval processing.
Source Code Biol Med
2016
26005866
Spatial genomic heterogeneity within localized, multifocal prostate cancer.
Nat Genet
2015
25456371
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
Lancet Oncol
2014
25415046
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.
Oncotarget
2014
23522120
Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient.
BMC Cancer
2013
23918607
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair.
Clin Cancer Res
2013
23941291
Identification of three new cis-regulatory IRF5 polymorphisms: in vitro studies.
Arthritis Res Ther
2013
23775540
Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.
J Pathol
2013
22619380
Epigenetic markers of prostate cancer in plasma circulating DNA.
Hum Mol Genet
2012
23022098
An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect.
Am J Hum Genet
2012
21173033
RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression.
Genome Res
2011
22032724
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
BMC Med Genomics
2011
21730106
What can exome sequencing do for you?
J Med Genet
2011
20518025
Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next-generation exome sequencing.
Hum Mutat
2010
20887961
Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome.
Am J Hum Genet
2010
1 - 34 of 34
Column Actions
Search
Recommended Authors
Job van Riet
Erasmus MC Cancer Institute
Career Start Year
2017
Number of shared co-authors
6
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year
2014
Number of shared co-authors
12
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
2011
Number of shared co-authors
8
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year
2009
Number of shared co-authors
0
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
12
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
2006
Number of shared co-authors
10
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
19
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
1
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year
2005
Number of shared co-authors
17
Joachim Weischenfeldt
University of Copenhagen
Career Start Year
2004
Number of shared co-authors
22
David W Craig
University of Southern California
Career Start Year
2004
Number of shared co-authors
5
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
0
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
4
Obi L Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
8
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
38
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year
2003
Number of shared co-authors
3
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year
2000
Number of shared co-authors
6
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
9
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year
1999
Number of shared co-authors
3
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year
1999
Number of shared co-authors
14
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year
1998
Number of shared co-authors
5
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
4
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year
1996
Number of shared co-authors
19
Adam Butler
Wellcome Sanger Institute
Career Start Year
1996
Number of shared co-authors
19
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1994
Number of shared co-authors
4
Marco A Marra
University of British Columbia
Career Start Year
1993
Number of shared co-authors
25
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year
1992
Number of shared co-authors
10
Elaine R Mardis
The Ohio State University
Career Start Year
1988
Number of shared co-authors
11
row(s) 1 - 30 of 30
Collaborators
Paul C Boutros
University of California los angeles
Co-authored papers
18
Robert G Bristow
University of Toronto
Co-authored papers
12
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
11
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
9
Julie Livingstone
University of California los angeles
Co-authored papers
7
Syed Haider
Institute of Cancer Research
Co-authored papers
6
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers
6
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers
6
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers
5
Clement Fung
Ontario Institute for Cancer Research
Co-authored papers
5
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers
5
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Co-authored papers
5
Kenneth C Chu
Ontario Institute for Cancer Research
Co-authored papers
5
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers
5
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers
5
Daryl Waggott
Ontario Institute for Cancer Research
Co-authored papers
5
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers
5
Alice Meng
Tufts University School of Medicine
Co-authored papers
5
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers
4
Christine P'ng
Ontario Institute for Cancer Research
Co-authored papers
4
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers
4
Arupa Ganguly
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
4
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers
4
Nicholas J Harding
Big Data Institute, University of Oxford
Co-authored papers
4
Neil E Fleshner
University of Toronto
Co-authored papers
4
Colin C Collins
University of British Columbia
Co-authored papers
4
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
4
Natalie S Fox
University of California los angeles
Co-authored papers
4
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Adrian Ishkanian
Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers
3
1 - 30